Biomolecular Life Holdings, Inc. BIOM
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.13% | -0.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.13% | -0.93% | |||
| Operating Income | 5.13% | 0.93% | |||
| Income Before Tax | -191.20% | -318.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -191.20% | -318.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -191.20% | -318.24% | |||
| EBIT | 5.13% | 0.93% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 75.63% | -315.58% | |||
| Normalized Basic EPS | 75.64% | -315.06% | |||
| EPS Diluted | 75.63% | -315.58% | |||
| Normalized Diluted EPS | 75.64% | -315.06% | |||
| Average Basic Shares Outstanding | 1,094.65% | 0.64% | |||
| Average Diluted Shares Outstanding | 1,094.65% | 0.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||